Dr Seerapani Gopaluni

Research and Publication

• M McClure, S Gopaluni et al, A randomised study of rituximab and belimumab
  sequential therapy in PR3 ANCAassociated vasculitis (COMBIVAS): design of the
  study protocol. DOI: 10.21203/rs.3.rs-2138639/v1, March 2023.
• S Gopaluni, R Smith, D Jayne et al, Alemtuzumab for refractory primary systemic
  vasculitis—a randomised controlled dose ranging clinical trial of efficacy and safety
  (ALEVIATE), April 2022, Arthritis Research & Therapy 24(1), DOI:
  10.1186/s13075-022-02761-6
• J Tieu, R Smith, S Gopaluni, et al. Rituximab Associated Hypogammaglobulinemia in
  Autoimmune Disease, May 2021, Frontiers in Immunology 12, DOI:
  10.3389/fimmu.2021.671503
• T Helper Cell Dysfunction in ANCA Associated Vasculitis, Dr S Gopaluni, PhD
  Thesis – University of Cambridge, March 2021
• McClure, M. E., Zhu, Y., Smith, R. M., Gopaluni, S., Tieu, J., Pope, T., … Jones, R.
  B. (2021). Long-term maintenance rituximab for ANCA-associated vasculitis: relapse
  and infection prediction models. Rheumatology, 60(3), 1491–1501.
  https://doi.org/10.1093/rheumatology/keaa541
• Rutherford, M. A., Scott, J., Karabayas, M., Antonelou, M., Gopaluni, S., Gray, D., …
  Basu, N. (2021). Risk factors for severe outcomes in patients with systemic vasculitis
  & COVID‐19: a bi‐national registry‐based cohort study. Arthritis &
  Rheumatology, art.41728. https://doi.org/10.1002/art.41728
• Trivioli, G., Gopaluni, S., Urban, M. L., Gianfreda, D., Cassia, M. A., Vercelloni, P.
  G., … Vaglio, A. (2021). Slowly progressive anti-neutrophil cytoplasmic antibodyassociated
  renal vasculitis: clinico-pathological characterization and outcome. Clinical
  Kidney Journal, 14(1), 332–340. https://doi.org/10.1093/ckj/sfaa139
  Rutherford, M. A., Scott, J., Karabayas, M., Antonelou, M., Gopaluni, S., Gray, D., …
  Basu, N. (2021). Risk factors for severe outcomes in patients with systemic vasculitis
  & COVID‐19: a bi‐national registry‐based cohort study. Arthritis &
  Rheumatology, art.41728. https://doi.org/10.1002/art.41728(Rutherford et al., 2021)
• Wagner J, Harrison E. M, Martinez M, Pero D, Blane B, Mayer G, Leierer J,
  Gopaluni S, Holmes M A, Parkhill J, Peacock S J, Jayne D R, Kronbichler A (2019).
  The composition and functional protein subsystems of the human nasal microbiome in
  granulomatosis with polyangiitis : a pilot study. Microbiome (2019) 7:137
  https://doi.org/10.1186/s40168-019-0753-z
• Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis.
  McClure ME, Wason J, Gopaluni S, Tieu J, Smith RM, Jayne DR, Jones RB. J Clin
  Rheumatol. 2019 Mar 20. doi: 10.1097/RHU.0000000000001030.
• A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm
  antibody-associated vasculitis. Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J,
  Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones
  RB, Jayne D, Little MA, Pusey CD, Salama AD. Rheumatology (Oxford). 2019 Feb
  1;58(2):260-268. doi: 10.1093/rheumatology/key288.
• Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term
  Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Gopaluni S,
  Flossmann O, Little MA, O'Hara P, Bekker P, Jayne D; European Vasculitis Society.
  Arthritis Rheumatol. 2019 May;71(5):784-791. doi: 10.1002/art.40776. Epub 2019 Mar
  28.
• B cell therapy in ANCA-associated vasculitis: current and emerging treatment options.
  McClure M, Gopaluni S, Jayne D, Jones R. Nat Rev Rheumatol. 2018 Oct;14(10):580-
  591. doi: 10.1038/s41584-018-0065-x. Epub 2018 Aug 14. Review.
• A retrospective study comparing the phenotype and outcomes of patients with
  polyarteritis nodosa between UK and Turkish cohorts. Karadag O, Erden A, Bilginer
  Y, Gopaluni S, Sari A, Armagan B, Ertenli I, Ozen S, Jayne D. Rheumatol Int. 2018
  Oct;38(10):1833-1840. doi: 10.1007/s00296-018-4122-1. Epub 2018 Aug 11.
• Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections
  following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.
  Kronbichler A, Kerschbaum J, Gopaluni S, Tieu J, Alberici F, Jones RB, Smith RM,
  Jayne DRW. Ann Rheum Dis. 2018 Oct;77(10):1440-1447. doi: 10.1136/annrheumdis-
  2017-212861. Epub 2018 Jun 27.
• McAdoo, S. P., Medjeral-Thomas, N., Gopaluni, S., Tanna, A., Mansfield, N.,
  Galliford, J., Griffith, M., et al. (2018). Long-term follow-up of a combined rituximab
  and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated
  vasculitis.. Nephrology, dialysis, transplantation : official publication of the European
  Dialysis and Transplant Association - European Renal Association, 2018, 33 (5), 899.
  https://doi.org/10.1093/ndt/gfy075
• Gopaluni, S., Smith, R. M., Lewin, M., McAlear, C. A., Mynard, K., Jones, R. B.,
  Jayne, D. R. W. (2017). Rituximab versus azathioprine as therapy for maintenance of
  remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM):
  study protocol for a randomized controlled trial. Trials, 18(1), 112.
  http://doi.org/10.1186/s13063-017-1857-z
  Gopaluni, S., Sherif, M., & Ahmadouk, N. A. 2016. Cochrane systematic review:
  Interventions for chronic kidney disease-associated restless legs syndrome. Cochrane
  Database of Systematic Reviews. doi: 10.1002/ 14651858. CD010690.pub2
• Gopaluni, S., & Jayne, D. (2016). Clinical Trials in Vasculitis. Current Treatment
  Options in Rheumatology, 2(2), 161–177. doi:10.1007/s40674-016-0045-8
• Gopaluni, S. and Jayne, D. 2015. Immune Vasculitis. eLS. 1–8. DOI:
  10.1002/9780470015902.a0002150.pub3
• Hindocha, S., Gopaluni, S., Collins, G. P., & Shenbagaraman, P. (2015). Focal
  segmental glomerulosclerosis in a patient with mantle cell lymphoma. BMJ Case
  Reports, 2015. doi:10.1136/bcr-2015-211765
• Gopaluni, S., Gibson, M., & Mohteshamzadeh, M. (2014). An unusual case of familial
  cystic kidney disease. Clinical Kidney Journal, 7(5), 484–485. doi:10.1093/ckj/sfu075
• Gopaluni, S., Sherif, M., & Ahmadouk, N. A. (2013). Protocol- Interventions for
  chronic kidney disease-associated restless legs syndrome. Cochrane Database of
  Systematic Reviews. doi:10.1002/14651858.CD010690.
• Ball MJ, Gopaluni S, Mathavakkannan S, Brian M, and Farrington K. An
  immunocompromised dialysis patient with skin and bone lesions. NDT Plus 2010 0:
  sfq010v1-sfq010; doi:10.1093/ndtplus/sfq010
• S Gopaluni, S Lines, AJP Lewington, Acute kidney injury in the critically ill patient,
  Current Anaesthesia & Critical Care 21 (2), 60-64, April 2010
• Seerapani Gopaluni, Aadil Shaukat, Martin Gray, Roshni Gokhale and M Al-Bustami
  Premature myocardial infarction presenting with acuacutete pulmonary embolism: a
  case report. Journal of Medical Case Reports 2009, 3:8786